Sonoma Pharmaceuticals
SNOA
Sonoma Pharmaceuticals (SNOA) news
Recent news
Sonoma Pharmaceuticals Q1 gross profit USD 2.6 million
AInvest Wire · Aug 6, 2026Sonoma Pharmaceuticals Q1 EBITDA USD 100 thousand
AInvest Wire · Aug 6, 2026Sonoma Pharmaceuticals Q1 revenue USD 6.4 million
AInvest Wire · Aug 6, 2026Sonoma Pharmaceuticals Q1 operating expenses USD 2.6 million
AInvest Wire · Aug 6, 2026Sonoma Pharmaceuticals - increases maximum aggregate offering price of common stock to $3.64 mln - SEC filing
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) recently announced a public offering of its common stock with a maximum aggregate offering price of $3.64 million, according to a SEC filing. The offering includes 2,962,963 shares of common stock and an equal number of warrants, with each share priced at…
AInvest Wire · Jun 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.